Earnings
Key Metrics
Income Statement
Balance Sheet
Cash Flow
Shareholder Return
Reporting period: 2025.01.01-2025.12.31
Summary: NTES (09999) reported Revenue of 112.63B（+6.96%）; Operating profit of 35.83B（+21.13%）; Net profit attributable to owners of 33.76B（+13.68%）.
Reported YoY
Prior Year YoY
Net profit attributable to owners Up YoY
Net profit attributable to owners
Reporting period: 2026.01.01-2026.06.30
Summary: NTES (09999) reported Revenue of 60.70B（+7.01%）; Operating profit of 24.75B（+26.89%）; Net profit attributable to owners of 17.65B（-6.60%）.
Reported YoY
Prior Year YoY
Operating profit Up YoY
19.50B --
Net profit attributable to owners Down YoY
18.90B --
Net profit attributable to owners
Unit: CNY
FY 2017
FY 2018
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
Gross margin 56.36% -- 53.43% 53.27% -- -- 53.62% -- 54.68% 60.95% 62.50% 64.29%
Net margin 24.41% -- 12.66% 36.18% -- -- 19.38% -- 20.56% 28.37% 28.73% 30.90%
ROE 23.41% -- 13.60% 34.56% -- -- 17.68% -- 19.42% 23.67% 21.41% 21.06%
ROA 15.27% -- 7.45% 19.11% -- -- 11.05% -- 11.49% 15.79% 15.44% 15.72%
Revenue growth -- -- 15.17% -- 15.75% -- -- -- -- 10.15% -- 7.23% 1.77% 6.96%
Attributable profit growth -- -- -42.54% -- 245.19% -- -- -- -- 20.65% -- 44.64% 0.96% 13.68%
Debt-to-assets 33.76% -- 40.88% 34.86% -- -- 35.29% -- 36.98% 31.11% 27.30% 25.43%
Current ratio 2.61 -- 1.96 2.23 -- -- 2.24 -- 2.32 2.65 3.09 3.45
Operating cash flow / net profit 1.10 -- 2.07 0.80 -- -- 1.47 -- 1.40 1.20 1.31 1.46
Operating cash flow / revenue 26.76% -- 26.21% 29.06% -- -- 28.45% -- 28.72% 34.15% 37.68% 45.05%
Unit: CNY
H1 2025
H1 2026
H1 2026
Gross margin 64.41% -- 69.36% -- 69.91%
Net margin 34.62% -- 35.45% -- 29.68%
Revenue growth -- -- -- -- 7.01% --
Attributable profit growth -- -- -- -- -6.60% --
Debt-to-assets -- -- -- -- 26.12% --
Current ratio -- -- -- -- 3.45 --
Operating cash flow / net profit 1.17 -- 1.27 -- 1.32
Operating cash flow / revenue 40.49% -- 44.89% -- 39.06%
Unit: CNY
FY 2017
FY 2018
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
Revenue 44.44B -- 51.18B 59.24B -- -- 87.61B -- 96.50B 103.47B 105.30B 112.63B
Cost of sales 19.39B -- 23.83B 27.69B -- -- -- -- -- -- -- -- -- -- -- --
Gross profit 25.04B -- 27.35B 31.56B -- -- 46.97B -- 52.77B 63.06B 65.81B 72.40B
Selling and distribution expenses 5.50B -- 6.91B 6.22B -- -- 12.21B -- 13.40B 13.97B 14.15B 14.62B
Administrative expenses 2.38B -- 3.08B 3.13B -- -- 4.26B -- 4.70B 4.90B 4.55B 4.23B
Income tax 2.16B -- 2.46B 2.91B -- -- 4.13B -- 5.03B 4.70B 5.46B 6.03B
Operating profit 12.99B -- 9.98B 13.79B -- -- 16.42B -- 19.63B 27.71B 29.58B 35.83B
Profit before tax 13.84B -- 11.08B 16.38B -- -- 21.10B -- 24.25B 34.06B 35.72B 40.83B
Net profit 10.85B -- 6.48B 21.43B -- -- 16.98B -- 19.84B 29.36B 30.26B 34.80B
Net profit attributable to owners 10.71B -- 6.15B 21.24B -- -- 16.86B -- 20.34B 29.42B 29.70B 33.76B
Unit: CNY
H1 2025
H1 2026
H1 2026
Revenue 56.72B -- 30.59B -- 60.70B
Cost of sales 20.19B -- 9.37B -- 18.26B
Gross profit 36.53B -- 21.22B -- 42.43B
Selling and distribution expenses 6.27B -- 3.44B -- 7.12B
Administrative expenses 2.01B -- 636.60M -- 1.44B
Income tax 3.47B -- 2.52B -- 4.98B
Operating profit 19.50B -- 12.66B -- 24.75B
Profit before tax 23.10B -- 13.37B -- 22.99B
Net profit 19.64B -- 10.85B -- 18.01B
Net profit attributable to owners 18.90B -- 10.67B -- 17.65B
Cash and cash equivalents
Unit: CNY
FY 2017
FY 2018
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
Cash and cash equivalents 2.47B -- 4.98B 3.25B -- -- 14.50B -- 24.89B 21.43B 51.38B 47.17B
Trade and bills receivables 3.54B -- 4.00B 4.17B -- -- 5.51B -- 5.00B 6.42B 5.67B 5.34B
Inventories 984.23M -- 1.07B 650.56M -- -- 964.73M -- 993.64M 695.37M 571.55M 689.18M
Total current assets 61.95B -- 68.72B 85.11B -- -- 113.12B -- 131.60B 142.69B 153.32B 180.62B
Total assets 71.03B -- 86.97B 112.12B -- -- 153.64B -- 172.76B 185.92B 195.99B 221.42B
Total current liabilities 23.75B -- 35.11B 38.24B -- -- 50.50B -- 56.83B 53.84B 49.67B 52.37B
Total liabilities 23.98B -- 35.56B 39.08B -- -- 54.22B -- 63.89B 57.84B 53.50B 56.31B
Equity attributable to owners 45.73B -- 45.23B 61.45B -- -- 95.33B -- 104.73B 124.29B 138.69B 160.30B
Total equity 46.44B -- 46.03B 62.59B -- -- 99.42B -- 108.87B 128.08B 142.49B 165.10B
Cash and cash equivalents
Unit: CNY
H1 2025
H1 2026
H1 2026
Cash and cash equivalents -- -- -- -- 22.81B --
Trade and bills receivables -- -- -- -- 5.75B --
Inventories -- -- -- -- 511.90M --
Total current assets -- -- -- -- 192.06B --
Total assets -- -- -- -- 232.21B --
Total current liabilities -- -- -- -- 55.62B --
Total liabilities -- -- -- -- 60.65B --
Equity attributable to owners -- -- -- -- 167.09B --
Total equity -- -- -- -- 171.47B --
Net cash from operating activities
Unit: CNY
FY 2017
FY 2018
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
Net cash from operating activities 11.89B -- 13.42B 17.22B -- -- 24.93B -- 27.71B 35.33B 39.68B 50.74B
Net cash from investing activities -12.86B -- -13.57B -22.14B -- -- -7.08B -- -7.37B -17.04B 17.92B -33.18B
Net cash from financing activities -- -- -- -- -- -- -- -- -12.59B -- -10.24B -21.47B -27.34B -20.16B
Net change in cash -- -- -- -- -- -- -- -- 5.21B -- 10.21B -3.38B 30.27B -2.98B
Net cash from operating activities
Unit: CNY
H1 2025
H1 2026
H1 2026
Net cash from operating activities 22.97B -- 13.73B -- 23.71B
Net cash from investing activities -8.95B -- -7.76B -- -42.42B
Net cash from financing activities -10.24B -- -1.80B -- -4.98B
Net change in cash 3.69B -- 3.83B -- -24.23B
Dividends
Dividend per share (last 12 months) 0.59 USD
Payments (last 12 months) 4
Sum of per-share cash dividends already ex-dividend, as of 2026-09-02; amounts in different currencies are not converted.
Buybacks
Total repurchased 360.65K HKD
Shares repurchased 197.73K
Buyback days 6
Cumulative since 2026-09-25 (from HKEXnews next-day disclosure returns; earlier records are not included).
Dividend Details
Dividend Details
Ex-date
Payment Date
Record Date
USD 0.096Quarterly
每股派美元0.096元(相当于港币0.75276元(计算值))
2026-09-02
2026-09-15
USD 0.144Quarterly
每股派美元0.144元(相当于港币1.127833元(计算值))
2026-06-04
2026-06-15
USD 0.232Quarterly
每股派美元0.232元(相当于港币1.813635元(计算值))
2026-03-13
2026-03-25
USD 0.114Quarterly
每股派美元0.114元(相当于港币0.887636元(计算值))
2025-12-04
2025-12-16
USD 0.114Quarterly
每股派美元0.114元(相当于港币0.894783元(计算值))
2025-08-27
2025-09-08
USD 0.135Quarterly
每股派美元0.135元(相当于港币1.053585元(计算值))
2025-05-29
2025-06-10
USD 0.244Quarterly
每股派美元0.24405元(相当于港币1.897984元(计算值))
2025-03-05
2025-03-17
USD 0.087Quarterly
每股派美元0.087元(相当于港币0.676899元(计算值))
2024-11-28
2024-12-10
USD 0.087Quarterly
每股派美元0.087元(相当于港币0.677909元(计算值))
2024-09-05
2024-09-17
USD 0.099Quarterly
每股派美元0.099元(相当于港币0.772686元(计算值))
2024-06-05
2024-06-17
USD 0.216Quarterly
每股派美元0.21597元(相当于港币1.690484元(计算值))
2024-03-13
2024-03-25
USD 0.099Quarterly
每股派美元0.099元(相当于港币0.772938元(计算值))
2023-11-30
2023-12-12
USD 0.105Quarterly
每股派美元0.105元(相当于港币0.823149元(计算值))
2023-09-07
2023-09-19
USD 0.093Quarterly
每股派美元0.093元(相当于港币0.728064元(计算值))
2023-06-08
2023-06-21
USD 0.054Quarterly
每股派美元0.054元(相当于港币0.423571元(计算值))
2023-03-08
2023-03-21
USD 0.087Quarterly
每股派美元0.087元(相当于港币0.680556元(计算值))
2022-12-01
2022-12-13
USD 0.072Quarterly
每股派美元0.072元(相当于港币0.564749元(计算值))
2022-08-31
2022-09-13
USD 0.0644Quarterly
每股派美元0.0644元(相当于港币0.505501元(计算值))
2022-06-07
2022-06-20
USD 0.081Quarterly
每股派美元0.081元(相当于港币0.632183元(计算值))
2022-03-10
2022-03-22
USD 0.045Quarterly
每股派美元0.045元(相当于港币0.350507元(计算值))
2021-11-30
2021-12-13
USD 0.048Quarterly
每股派美元0.048元(相当于港币0.373732元(计算值))
2021-09-13
2021-09-27
USD 0.06Quarterly
每股派美元0.06元(相当于港币0.465978元(计算值))
2021-06-02
2021-06-15
USD 0.012Quarterly
每股派美元0.012元(相当于港币0.093055元(计算值))
2021-03-11
2021-03-23
USD 0.039Quarterly
每股派美元0.039元(相当于港币0.302334元(计算值))
2020-12-03
2020-12-15
USD 0.0594Quarterly
每股派美元0.0594元(相当于港币0.460416元(计算值))
2020-08-27
2020-09-14
USD 0.0464Quarterly
每股派美元0.0464元(相当于港币0.359629元(计算值))
2020-06-11
2020-06-23
Financial data: HKEXnews annual and interim reports; pre-listing years from the prospectus. YoY for ratios is the change in percentage points; ROE and ROA use annual reports only.
About this page
This page shows NTES (09999) historical financial statements and corporate actions. Financial data comes from public financial disclosures in HKEX display documents, grouped by reporting period; corporate actions come from HKEXnews announcements.
Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect
